))
Episode 23 - 2Q 2020 Results Bring Estimate Increases, But Can The Fed Inoculate The Economy?
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on February 26, 2024 14:59 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 280069225 series 2839981
Content provided by Laidlaw Wealth Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Laidlaw Wealth Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode Richard Calhoun, CEO of Laidlaw Wealth Management, discusses takeaways from the 2Q 2020 earnings season, the ongoing complications from COVID and other developments with Laidlaw & Company Chief Market strategist, David Garrity.
The topics discussed in this episode are: With 2Q 2020 results prompting analysts to raise estimates, are stocks still attractive?, Are management share sales a red flag for stocks? Can The Fed fully offset COVID’s economic impact?, How might investors capitalize on the weakening U.S. Dollar?, and How should investors best operationalize “Quality” in portfolio construction?
66 episodes
Share
